Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Authors: Klok RM; Pfizer bv, Capelle a/d IJssel, The Netherlands. rogier.klok@pfizer.com, Lindkvist RM, Ekelund M, Farkouh RA, Strutton DR
Source: Clinical therapeutics [Clin Ther] 2013 Feb; Vol. 35 (2), pp. 119-34. Date of Electronic Publication: 2013 Jan 10.
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-114X
DOI:10.1016/j.clinthera.2012.12.006